Lighthouse Biotech
Patentable Molecule Derivates for Mental Health Therapies
The Hi-Lites
- Lighthouse is a European drug development company commencing pre-clinical trials for the development of novel patentable molecular derivates.
- Lighthouse is developing psychedelic therapies aimed at addressing a number of pervasive mental health conditions.
- Lighthouse is in the last stages of being able to produce pharmaceutical grade synthetic psylocibin for both research as well as for export.
- Lighthouse will conduct research and produce synthetic psylocibin in a state of the art GLP approved lab, situated within a top university in Serbia. Additionally, Lighthouse is in the late stages for receiving a set of licenses in Montenegro to manufacture and export a wide range of psychedelic API’s at scale.
- Lighthouse is led by experienced entrepreneurs working alongside top medical researchers to create transformative modalities addressing mental health conditions.
